Bio-Path Holdings, Inc. (BPTH) Balance Sheet

OTCQX: BPTHAssets, liabilities, debt and equity over 10 years.

BPTH balance sheet, 2024

December 31, 2024 · U.S. dollars

$3.9M assets = $3.7M liabilities + $154,000 equity

What it owns$3.9MCash & ST investments: $1.2M (30.2%)Cash & ST investments$1.2M · 30%Other current: $2.6M (67.0%)Other current$2.6M · 67%PP&E: $107,000 (2.8%)=How it is financed$3.9MCurrent liabilities: $3.3M (84.9%)Current liabilities$3.3M · 85%Other LT liabilities: $434,000 (11.2%)$434,000Shareholders’ equity: $154,000 (4.0%)

Both columns are drawn to the same scale: what BPTH owns equals what it owes plus shareholders’ equity. Hover a block for its value.

BPTH financial health

Current ratio1.15
Adequate · current assets cover current liabilities 1.15×
Equity / assets4.0%
Thin equity · of assets funded by shareholders
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2024.

BPTH balance sheet trends, 2015–2024

Bio-Path Holdings, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$10.8M2015$3.9M2024−10.7%/yr
Total liabilities$937,4102015$3.7M2024+16.6%/yr
Shareholders’ equity$9.8M2015$154,0002024−37.0%/yr
Cash & short-term investments$8.9M2015$1.2M2024−20.1%/yr
Total debt$415,0002019$113,0002023−27.8%/yr
Net cash (debt)$20.0M2019$939,0002023−$19.1M
Working capital$8.7M2015$481,0002024−$8.2M
Current ratio10.2320151.152024−9.09
Debt / equity0.0220190.262023+0.24

Change is the average annual growth (CAGR) or the difference between the first and latest year.

BPTH assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

BPTH liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

BPTH debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

BPTH balance sheet

Bio-Path Holdings, Inc. annual balance sheet
2024202320222021202020192018201720162015
Assets
Cash & short-term investments$1.2M$1.1M$10.4M$23.8M$13.8M$20.4M$1.0M$6.0M$9.4M$8.9M
Cash & equivalents$1.2M$1.1M$10.4M$23.8M$13.8M$20.4M$1.0M$6.0M$9.4M$8.9M
Short-term investments———————$0$0$0
Receivables$0$0−$3,587−$523$0$775,224$0$0$0$0
Inventory$0$632$3,587$523$1,273$776$0$0$0$559,515
Other current assets$2.6M$2.0M$5.2M$2.4M$2.2M$788,000$925,000$1.5M$1.3M$178,977
Total current assets$3.8M$3.0M$15.6M$26.1M$16.0M$22.0M$1.9M$7.4M$10.7M$9.6M
Property, plant & equipment (net)$107,000$178,000$356,000$428,000$519,000$670,000$406,000$654,000$614,000$71,989
Goodwill & intangible assets$0$0$0$0$0$0$0$769,000$929,000$1.1M
Long-term investments$0$0$0$0$0$0$0$0$0$0
Other non-current assets$0$0$0$0$0$0$0$0$0$0
Total assets$3.9M$3.2M$16.0M$26.6M$16.5M$22.7M$2.3M$8.9M$12.2M$10.8M
Liabilities
Accounts payable$1.3M$457,000$667,000$106,000$100,000$486,000$813,000$52,000$69,000$54,581
Short-term debt—$103,000$216,000$164,000$188,000$85,000————
Deferred revenue————————$12,000—
Total current liabilities$3.3M$1.9M$1.7M$958,000$1.2M$1.2M$1.1M$791,000$1.1M$937,410
Long-term debt$0$0$0$0$0$0$0$0$0$0
Lease obligations$83,000$113,000$221,000$235,000$330,000$415,000————
Other long-term liabilities$434,000$873,000$113,000$153,000$236,000$330,000$813,000$52,000$2.9M$54,581
Total liabilities$3.7M$2.8M$1.8M$1.1M$1.4M$1.6M$1.1M$791,000$4.0M$937,410
Shareholders' equity
Common stock & paid-in capital—$1,000$8,000$7,000$5,000$4,000$1,000$11,000$96,000$89,763
Retained earnings (deficit)−$117.5M−$107.6M−$91.5M−$77.7M−$67.2M−$56.3M−$47.7M−$39.2M−$32.1M−$25.4M
Treasury stock———————$0$0$0
Accumulated other comprehensive income—————$0−$592,000−$330,000−$94,000−$51,421
Minority interest———————$0$0$0
Total shareholders' equity$154,000$441,000$14.2M$25.5M$15.1M$21.1M$1.2M$8.1M$8.2M$9.8M
Key figures
Total debt—$113,000$221,000$235,000$330,000$415,000————
Net cash (debt)—$939,000$10.2M$23.5M$13.4M$20.0M————
Working capital$481,000$1.1M$13.9M$25.2M$14.8M$20.7M$812,000$6.6M$9.6M$8.7M
Tangible book value$154,000$441,000$14.2M$25.5M$15.1M$21.1M$1.2M$7.3M$7.3M$8.7M
Current ratio1.151.609.2727.2913.6517.681.739.4010.1510.23
Quick ratio0.360.556.1624.8211.7717.040.907.548.939.45
Debt / equity—0.260.020.010.020.02————
Equity / assets4.0%13.7%88.7%95.8%91.5%93.1%52.2%91.1%67.6%91.3%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed —); data from EODHD.

BPTH financial position

At the end of fiscal 2024 (December 31, 2024), Bio-Path had total assets of $3.9 million (up 20.6% from a year earlier), total liabilities of $3.7 million and shareholders' equity of $0.2 million. Its current ratio was 1.15. In the latest quarter (ended March 31, 2026) total assets were $0.7 million and equity -$8.5 million.

Related: BPTH income statement, BPTH cash flow statement, BPTH key metrics. See the BPTH stock overview for the latest quote and news.

BPTH balance sheet FAQ

What are Bio-Path's total assets?

Bio-Path reported total assets of $3.9 million at the end of fiscal 2024 (December 31, 2024), compared with $3.2 million a year earlier.

How much cash does Bio-Path have?

Bio-Path held $1.2 million in cash and short-term investments at the end of fiscal 2024.

What is Bio-Path's book value?

Bio-Path's shareholders' equity (book value) was $0.2 million at the end of fiscal 2024.

What is Bio-Path's current ratio?

Bio-Path had current assets of $3.8 million and current liabilities of $3.3 million, a current ratio of 1.15 (it can cover its short-term obligations).

Biotechnology: balance sheet